Off-market insider buying at Canada House Wellness Gro (CHV)

Off-market insider buying at Canada House Wellness Gro (:CHV)

Updated Thursday Feb 06, 2020 02:57 AM EDT
Pursuant to a debt settlement agreement with the Company, Fabian Daniel Henry, a 10% Holder, acquired 30,000,000 Common Shares on a direct ownership basis at a price of $0.050 through a private transaction on February 5th, 2020. This represents an account share holdings change of greater than 100%.

Canada House Wellness Gro is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Canada House Cannabis Group Inc., formerly Canada House Wellness Group Inc, is a Canada-based cannabis company engaged in providing cannabinoid therapy products and services. The Company's operated subsidiaries are: Canada House Clinics, Knalysis Technologies Inc and Abba Medix Corp. Its Canada House Clinics is focused on treating complex health issues through assessments, ongoing support, and data-driven treatment plans that are monitored by cannabinoid therapy educators. Its Knalysis Technologies, is a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis. Its Abba Medix Corp is engaged in producing cannabis genetics and products in a fully integrated seed-to-sale vertical and links the growth operations, patient services, and offers artificial intelligence (AI) assisted data reporting solutions.


Top